1. Home
  2. NTRA vs KMB Comparison

NTRA vs KMB Comparison

Compare NTRA & KMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$277.90

Market Cap

29.1B

Sector

Health Care

ML Signal

HOLD

Logo Kimberly-Clark Corporation

KMB

Kimberly-Clark Corporation

HOLD

Current Price

$114.73

Market Cap

31.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
KMB
Founded
2003
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
29.1B
31.5B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
NTRA
KMB
Price
$277.90
$114.73
Analyst Decision
Strong Buy
Hold
Analyst Count
15
13
Target Price
$259.07
$113.54
AVG Volume (30 Days)
1.5M
4.5M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
5.33%
EPS Growth
0.65
N/A
EPS
N/A
2.00
Revenue
$210,939,000.00
$16,447,000,000.00
Revenue This Year
$18.08
$3.83
Revenue Next Year
$19.65
$3.61
P/E Ratio
N/A
$57.37
Revenue Growth
N/A
N/A
52 Week Low
$131.81
$92.42
52 Week High
$279.42
$137.46

Technical Indicators

Market Signals
Indicator
NTRA
KMB
Relative Strength Index (RSI) 78.21 76.11
Support Level $186.96 $97.78
Resistance Level N/A $124.21
Average True Range (ATR) 13.08 2.36
MACD 4.73 1.05
Stochastic Oscillator 99.56 97.95

Price Performance

Historical Comparison
NTRA
KMB

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About KMB Kimberly-Clark Corporation

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.

Share on Social Networks: